Delivery Order SPE2DB24D2205-SPE2DB25FEFSJ
- Not listed
- The Defense Logistics Agency awarded a $47,704.56 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $3,577.74. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The award will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is a child contract under AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $44,107.24 under firm fixed-price terms. The contract, which is classified as a child order under a larger indefinite delivery vehicle, requires completion by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-competitive set-aside order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Dupixent 300 mg/2 mL syringes valued at $4,991.39. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete purchase under AmerisourceBergen's existing contract vehicle with the DLA. AmerisourceBergen Drug Corp is a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Dupixent 300mg/2ml syringes valued at $44,390.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not utilize a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,418.92 under a firm fixed-price contract. This award represents a non-set-aside competitive procurement and is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a $4,791.86 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dupixent 300 mg/2 ml syringes (2 ml volume). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,709.46 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on July 21, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dupixent 300 mg/2 ml syringes, with a ceiling value of $10,375.34. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive pharmaceutical supply relationship with the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $62,693.40. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, delivers this order as part of its comprehensive pharmaceutical supply portfolio supporting military and veteran healthcare systems. The delivery order falls within the company's significant $999,999,999.00 SPE2DX IDC with DLA Troop Support Medical, which runs through December 2026 and provides global pharmaceutical support for military healthcare programs. Dupixent, a specialty pharmaceutical for immunological conditions, represents the type of specialized medication that AmerisourceBergen routinely supplies to federal healthcare entities through its primary vendor relationships with the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.7k | 8/1/25 |